CN Patent
CN1034216C — 7-(取代)-9-[(取代甘氨酰)酰氨基]-6-脱甲基-6-脱氧四环素
Assigned to Wyeth Holdings LLC · Expires 1997-03-12 · 29y expired
What this patent protects
本发明提供如下式的化合物: 其中R,R 3 ,R 4 和W如说明书中定义,这些化合物作为抗菌剂用。
USPTO Abstract
本发明提供如下式的化合物: 其中R,R 3 ,R 4 和W如说明书中定义,这些化合物作为抗菌剂用。
Drugs covered by this patent
- Xerava (ERAVACYCLINE DIHYDROCHLORIDE) · Tetraphase Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.